About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Glenmark to Start Phase II Trials for Experimental Drug for Treating Crohn’s Disease

by Kathy Jones on September 14, 2012 at 8:58 PM
Font : A-A+

 Glenmark to Start Phase II Trials for Experimental Drug for Treating Crohn’s Disease

Mumbai based drug maker Glenmark Pharmaceuticals revealed that it will starting the phase II clinical trials to test the effectiveness of its experimental drug for treating Crohn's disease and other inflammatory conditions in humans.

The trials are being conducted in collaboration with Sanofi to test whether the drug, GBR 500, is effective in treating inflammatory conditions such as Crohn's disease, multiple sclerosis and ulcerative colitis.

Advertisement

The trials are being conducted at multiple clinical sites in North America and Europe by its subsidiary company Glenmark Pharmaceuticals SA.

Glenmark Pharmaceuticals Chief Scientific Officer Michael Buschle revealed that the phase II trials will be expanding the sample base to 100-300 people. "Despite treatment advances in recent years, UC remains a debilitating condition for many individuals, and represents an area of substantial unmet medical need", he said.



Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity Ulcerative Colitis Crohns Disease 

Most Popular on Medindia

Find a Hospital Sanatogen Noscaphene (Noscapine) Diaphragmatic Hernia Calculate Ideal Weight for Infants Nutam (400mg) (Piracetam) Drug Side Effects Calculator Post-Nasal Drip The Essence of Yoga Hearing Loss Calculator
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT ONLINE WITH A DOCTOR

×

Glenmark to Start Phase II Trials for Experimental Drug for Treating Crohn’s Disease Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests